Clovis Oncology
CLVS
#10292
Rank
NZ$19.54 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-95.45%
Change (1 year)

Clovis Oncology (CLVS) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : NZ$1.26 Billion

According to Clovis Oncology's latest financial reports the company's total liabilities are NZ$1.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Clovis Oncology - Total liabilities on balance sheet (from 2010 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31NZ$1.10 B3.89%
2020-12-31NZ$1.05 B-15.46%
2019-12-31NZ$1.25 B17.21%
2018-12-31NZ$1.06 B106.54%
2017-12-31NZ$0.51 B-2.62%
2016-12-31NZ$0.53 B-11.86%
2015-12-31NZ$0.60 B3.94%
2014-12-31NZ$0.58 B214.18%
2013-12-31NZ$0.18 B1115.48%
2012-12-31NZ$15.19 M1.76%
2011-12-31NZ$14.92 M-85.77%
2010-12-31NZ$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$188.52 B 14,748.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$192.00 B 15,022.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$226.63 B 17,750.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$151.23 B 11,811.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$113.71 B 8,856.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
NZ$2.58 B 103.77%๐Ÿ‡บ๐Ÿ‡ธ USA